Member Info for Spwcapital

Strong growth this year with a rerate beginning. Profitability in q2.

Great job Cathal Friel! Adding to his track record.

Stay safe everyone.

If this passes 317p soon, then it's heading for 585p.

I know someone trying to sell their Bitcoin to put them in shares, but his Bitfinex account has been blocked for 5 days since last week, and does not reopen until tomorrow late afternoon. He'll probably have to pay 300p for these shares tomorrow, if this continues.

GLA and Stay safe.

They are to begin on the first week of May 2020. Should therefore assume news will come soon.

Will wait.

GLA and stay safe.

We bought in around 9, 13, 18 and 20s. Now again at 14.9.

Knowing the company's net assets are larger than the market cap gives us confidence, along with news imminent soon. Still a bit shocked this is not in the mid 20s right now.

GLA and stay safe.

This is just based on chart analysis on where the next main resistance is after 195p. Between 195p and 317p there's hardly any resistance, and between 317p til 580p there's also not much resistance. We could easily reach over 580p, due to such low marketcap.

Larger investors will join this company no doubt, therefore we could reach over 500p, but this is depended on news and marketing of this company, because right now not many large investors have heard of Genedrive, especially those we've spoken to. But now word is spreading, so should see super large buys coming in this week and onwards.

GLA and stay safe.

Once past 195p, then next stop around 300p and onwards.

Topping up ourselves. Still confident price could see at least 300p in short term.

GLA and stay safe.

These are based on our own conservative figures, to not overestimate the company's valuation.

We believe the company will retest at least the 190p to 310p in the short term (May to July period). However based on future news, our conservative figures and valuations will change of course.

GLA and stay safe.

Our client sold a property and put their proceeds here, they managed to get in last Monday above 90p and has topped up again today.
We believe Genedrive is severely undervalued based on their ability to provide their covid 19 tests to developing countries and on basic revenue calculations for their tests:

10,000 tests per hour x 12 hours a day = 120,000 tests per day

120,000 tests x 365 days = 43,800,000 tests per year

43,800,000 tests x £2 (affordable sales figure per test) = £87,600,000 test revenue per year

£87,600,000 divided by 2 (with Cytiva) = £43,800,000

£43,800,000 x 5 (Pharma revenue calculations for marketcap) = £219,000,000 marketcap

The above calculations are based on conservative figures and Genedrive performing of course, which we are confident they will in the near future.

We expect a RNS this week or next, stating they are ahead of schedule with Cytiva, just like Avacta had posted with Cytiva.

GLA and do your own research. But most importantly stay safe.

Rough sales figures
45,000 tests x 365 days = 16,425,000 tests
16,425,000 tests x £10 = £164,250,000

£164,250,000 divided by 4 partners = £41,062,500 revenue

£41,062,500 revenue x 5 = £205m

GLA and stay safe

Just based on the £20m net assets alone, this share is far too undervalued.

When news drops, the share price would be in 50s, due to such low marketcap.

But we see support right now in mid 20s to 30s, short term.

GLA and stay safe.

What platform are you using? IG let us top up at 16.5?

Yesterday MMs were trying to take this down to between high 40s and 50s. Buying more still as we know the true value and potential. We certainty do not want to be caught out when this is realised by the masses.

Investors may be waiting on the sidelines to get in during the 40s, but remember, you could get caught out and miss this opportunity. We're not taking any risks and continuing to buy more.

GLA and stay safe.

Our net assets is valued at least £20m, anyone getting in at these prices are buying into an undervalued company. Soon investors will realise this. Topping up.

https://www.youtube.com/watch?v=DMGLlAfTy_0

GLA and stay safe

I saw the marketcap go from around £4m to £15m, yet the buys and sells were only around £400,000 and £500,000?

Spreadex should have sold in a month, to get a better rate in my opinion.
Each to their own I suppose.

To all investors, remember, it's WHEN fda approves, not if.

GLA

Nothing goes up in a straight line - MMs trying to bring this down to high 40s and mid 50s, don't fall for it, or could be buying back much higher. Hold your positions and you'll reap the rewards in May.

GLA and stay safe.

Shocking to see investors selling at such a low price, in a few weeks this would be worth in the pounds, mark our words.

Suppose investors are chasing other stocks, so this rerates a bit to the high 50s, but it is not worth it because an RNS can drop anytime soon and could achieve all time highs.

GLA

They are the largest shareholders of the company, and having invested in the early days they ought to take profit to derisk or profit from their investment.

Genedrive could reach over 550p again, especially if Novacyt a 300m market cap continues to grow. Genedrive is less than 30m marketcap and is still undervalued based on the future's covid 19 tests (on the basis of 10,000 tests per hour).

Genedrive's HCVD kit already gained "WHO qualified status", we are fully confident Genedrive is severely undervalued and will perform in a few weeks.

In December 2018 we invested a large sum of funds in Faron pharmaceuticals at 85p due to their potential and how undervalued they were, just like Genedrive, now Faron are now worth over 300p a share.

To note how confident we believe genedrive is undervalued, a client of ours is trying to sell a property below marketvalue to buy these shares.
This is an opportunity of a lifetime and companies working on test kits will be needed for over a year to come.

GLA - Stay safe.